Skip to main content
Download PDF

Natural agents mediated autophagic signal networks in cancer

Cancer Cell International volume 17, Article number: 110 (2017) Cite this article

Abstract

Recent studies suggested that natural compounds are important in finding targets for cancer treatments. Autophagy (“self-eating”) plays important roles in multiple diseases and acts as a tumor suppressor in cancer. Here, we examined the molecular mechanism by which natural agents regulate autophagic signals. Understanding the relationship between natural agents and cellular autophagy may provide more information for cancer diagnosis and chemoprevention.

Background

Autophagy, also called type II programmed cell death, is a catabolic process that leads to degradation of targeted organelles or cellular proteins. The first stage of the autophagic process is the formation of autophagosomes arising from intracellular membrane structures, such as the endoplasmic reticulum (ER), plasma membrane [1, 2], Golgi or endosome [1], and the ER‒mitochondrial contact site called the mitochondrion-associated ER membrane [2, 3].

The serine/threonine protein kinase target of rapamycin (TOR) acts as a central inhibitor of autophagy. In yeast, TOR inhibition mediates the kinase activity of autophagy-related gene (Atg) 1 and enhances the Atg1 binding affinity to Atg13 and Atg17 to initiate autophagosome formation [4]. The mammalian Atg13/focal adhesion kinase (FAK) family interacting protein of 200 kD (FIP200)/UNC-51-like kinase complex mediates mechanistic target of rapamycin (mTOR)-mediated autophagy induction [5, 6]. Multiple Atg proteins are required to form the phagophore in autophagosome formation. To initiate the phagophore, the membrane recruits PtdIns3K vacuolar protein sorting 34, the myristoylated serine/threonine kinase Vps15 (p150), Beclin 1, and Atg14 [6,7,8,9]. Next, the elongation and expansion stages require a ubiquitin-like system such as the ATG5/ATG12/ATG16L multimeric complex and microtubule-associated protein light chain 3 (LC3) processing [10]. Finally, when the autophagosome is mature, it fuses with the lysosome to form the ‘autolysosome’ to degrade organelles or cellular proteins.

Autophagy plays a role in several biological processes, such as aging, development, and differentiation [11, 12], and it is regulated by 5′ AMP-activated protein kinase (AMPK) and mTOR downstream of PI3 kinase/AKT, which control cell growth and protein synthesis [13]. When growth factors are withdrawn, the autophagosome forms to induce autophagy [14].

Autophagy and cancer: anti-tumorigenic effects of autophagy

Autophagy is both inhibitory and beneficial to malignant transformation [15, 16]. Mukubou et al. showed that enhanced sensitivity of pancreatic cancer cells to gemcitabine or ionizing radiation treatment activated autophagic flux [17]. Interference in the autophagic machinery in heterozygous or homozygous knockout mouse models resulted in oncogenesis [18]. Beclin 1, which regulates the initiation stages of autophagosome formation, plays a role as a tumor suppressor. Beclin 1−/− mice displayed tumorigenesis and altered early embryonic development [19]. Beclin 1+/− immortalized baby mouse kidney (iBMK) epithelial cells promoted tumorigenesis.

There is evidence that disruption of Atgs promotes tumor cell death induced by anti-cancer drugs, such as histone deacetylase inhibitors, temozolomide, and etoposide [20, 21]. Guo et al. showed that Atg7-deficient lung tumors with p53 deletion resulted in lipid accumulation [22]. Pyo et al. [23] reported that Atg5 regulates interferon-γ-induced autophagic cell death by interacting with Fas-associated protein with death domain, which is a key signaling molecule involved in cell death.

Autophagy and cancer: pro-tumorigenic effects of autophagy

Autophagy is constitutively activated in cancer cells, especially RAS-driven tumor cells [24, 25], and transcriptional control of autophagy- and lysosome-related genes induces pancreatic cancer metabolism [18]. Wei et al. [26] demonstrated that deletion of FIP200, which plays a role in autophagy, inhibits mammary tumorigenesis by impairing tumor cell proliferation in vivo in an oncogene-driven tumor model. There are several reports that accumulation of p62, which is a marker of autophagic flux, affects tumorigenesis and/or tumor progression. For instance, expression of p62 is highly induced in non-small-cell lung cancer [27] and breast cancer [28], and p62/SQSTM1-knockout mice showed inhibition of RAS-induced tumorigenesis compared with wild-type animals [29].

Autophagy and apoptosis

Beclin 1/Atg six is an essential component involved in formation of autophagic vesicles [30]. As shown in Fig. 1, Beclin 1 interacts with Bcl-2, which is an anti-apoptotic protein [31, 32], and inhibits autophagy. The interaction between Beclin 1 and Bcl-2 is via a BH3 domain in Beclin 1 [32, 33], and interference of this interaction was found to enhance autophagy [32].

Fig. 1
figure 1

The scheme of Beclin 1 and Bcl2 interaction. Beclin 1 forms a protein complex with VPS34. When Beclin 1 interacts with Bcl-2, Beclin1–Bcl-2 complex inhibits autophagy. However, when Beclin1–Bcl-2 complex dissociate, autophagy initiates

Full size image

There is evidence that caspases play important roles in autophagy and apoptosis [34]. Oral et al. [35] reported that caspase-8 overexpression resulted in Atg3 cleavage and thereby its degradation. Caspase 9 interacts with Atg7, and Caspase9–Atg7 complexes enhanced LC3II activity [35]. Zhu et al. [36] reported that caspase-3 plays an important role in autophagy via cleavage of Beclin-1 at positions 124 and 149. Therefore, crosstalk between autophagy and apoptosis may provide important information for cancer therapy.

Natural agents as modulators of autophagic signals

Several studies have revealed the therapeutic effectiveness of drug re-positioning of existing drugs and the use of newly developed drugs for the treatment of disease and tumors [37,38,39]. Natural agents have emerged as novel therapeutic agents of drug-repositioning to influence autophagic activity [3]. As shown in Fig. 2, several natural agents modulate autophagy. For example, tanshinone IIA [40], ursolic acid [41], quercerin [42], fisetin [43], resveratrol [44], and honokiol [45] act as inhibitors of the AKT/mTOR pathway. Tanshinone IIA modulates the initiation of phagophore formation. Ginsensoside [46] and ursolic acid [47] affect the formation of autophagosomes. Ginsenoside RO inhibits autophagosome–lysosome fusion [48].

Fig. 2
figure 2

The autophagic signal by natural agents. Curcumin, Tanshinone IIA, ursolic acid, quercetin, fisetin, resveratrol, and honokiol inhibit AKT/mTOR pathway. Tanshinone IIA and curcumin also enhance activation of AMPK which inhibits AKT/mTOR pathway. Tanshinone IIA modulates the initiation of phagophore formation. Ginsenoside 20(S) Rg-3, total tanshinone and ursolic acid enhance the formation of autophagosomes. Ginsenoside RO and [6]-Gingerol inhibit autophagosome–lysosome fusion

Full size image

Resveratrol

Resveratrol, a polyphenol phytoalexin found in grapes, possesses anti-cancer [49, 50] and antioxidant functions [51]. Resveratrol induced apoptosis and autophagy in ovarian cancer cells via inactivation of signal transducer and activator of transcription signaling [52] and induced autophagic cell death in prostate cancer cells via regulation of stromal interaction molecule 1 [53]. It also induced autophagy via downregulation of the Wnt/β-catenin signaling pathway in breast cancer stem-like cells [54]. Ge et al. [44] reported that resveratrol induced autophagy and apoptosis via repression of AKT/mTOR/p70S6K/4E-BP1 and enhancement of p38 MAPK signaling in T cell acute lymphoblastic leukemia cells.

Apigenin

Apigenin (4′,5,7-trihydroxyflavone), a naturally occurring flavone found in many fruits (apples, grapes), vegetables (onions, parsley), and tea, was shown to have chemopreventive effects in vitro and in vivo [55, 56]. Lee et al. [57] showed that apigenin induced autophagy in HCT116 human colon cancer cells, and when combined with 3MA, which inhibits autophagy, it increased apigenin-induced apoptosis in HCT116 cells. Autophagy inhibition enhanced apigenin-induced apoptosis in breast cancer T47D cells [58]. Apigenin induced autophagic cell death via reactive oxygen species (ROS) production and accumulation of G2/M cell cycle arrest in human papillary thyroid carcinoma cells [59].

Ursolic acid

Ursolic acid, a pentacyclic triterpenoid known for its anti-tumor effects [60, 61], increased the expression of LC3-II, an autophagosome marker, and induced autophagy via the Beclin-1 and AKT/mTOR pathways. In addition, treatment with 3-methyladeninet or Beclin-1/Atg5 siRNAs enhanced ursolic acid-mediated cell cytotoxicity in prostate cancer cells [62]. Xavier et al. [47] reported that ursolic acid induced accumulation of both LC3-II and p62 by activation of JNK in HCT15 cells. Zhao et al. [63] demonstrated that ursolic acid treatment induced autophagy via eukaryotic translation initiation factor 2-α kinase 3 activity, implying that ER stress is an important factor in autophagy. Leng et al. also demonstrated that ursolic acid treatment led to apoptosis in cervical cancer TC-1 cells and, according to transmission electron microscopy, resulted in autophagic vacuoles. siRNA-mediated knockdown of Atg5 combined with ursolic acid treatment in TC-1 tumor cells attenuated LC3 II accumulation, as shown by Western blotting, implying that the ursolic acid-induced autophagy relies on Atg5 [64].

Tanshinone

Tanshinones (tanshinone I and IIA) are derived from a traditional Chinese herb and are well-known bioactive herbal compounds with chemopreventive properties [65]. Tanshinone IIA activated LC3 II expression in various cancer cells, such as prostate and gastric cells [66, 67]. It also induced apoptosis and autophagy via the mTOR/p70S6K/AMPK pathway in KBM-5 leukemia cells [68]. Gao et al. [40] reported that treatment of 95D cells with total tanshinones upregulated the expression of autophagic proteins, such as Atg3, Atg5, Atg7, Atg12, Beclin-1, and LC3II, in a dose-dependent manner. Jing et al. demonstrated that tanshinone treatment of gastric cancer cells, such as BGC823 and SGC7901 cells, induced autophagy and attenuated tumor proliferation in nude mice bearing BGC823 tumor xenografts [66]. Tanshinone II treatment in human osteosarcoma MG63 cells upregulated Beclin, which is involved in the formation of autophagic vesicles, inducing autophagy and apoptosis via ROS [69].

Curcumin

Curcumin, a hydrophobic polyphenol, possesses anti-cancer functions in various human cancer cells, such as pancreatic and prostate cancer cells [70, 71]. Zhang et al. [72] reported that curcumin treatment of colon cancer HCT116 cells induces autophagy via inhibition of the AKT/mTOR signaling pathway and upregulation of the transcriptional activity of the transcription factor EB. Guan et al. [73] also demonstrated that curcumin treatment induced autophagy via activation of AMPK and suppressed the proliferation and migration of MDA-MB-231 breast cancer cells. Curcumin induced autophagy by upregulating the AMPK pathway in A549 lung adenocarcinoma cells as well [74]. Zhao et al. [75] showed that curcumin treatment induced autophagy and suppressed invasion and proliferation in human melanoma cells via inhibition of the AKT/mTOR pathway.

Ginsenoside

Kim et al. reported that ginsenoside Rg3 treatment of hepatocellular carcinoma, using a GFP-mRFP-LC3 construct, suppressed autophagic flux. Combined treatment with doxorubicin and ginsenoside Rg3 sensitized cells to death via inhibition of autophagic flux [76]. Ginsenoside 20(S)-Rg3 treatment of ovarian cancer cells inhibited cell growth and invasion while upregulating autophagic related molecules, such as LC3II, ATG5, and ATG7. Ginsenoside 20(S)-Rg3 treatment suppressed tumor growth while upregulating LC3II, ATG5, and ATG7 levels [46]. Zheng et al. [48] showed that ginsenoside RO (RO) treatment combined with chloroquine diphosphate did not enhance LC3 II accumulation in esophageal cancer, implying that RO inhibits autophagosome–lysosome fusion.

Fisetin

Fisetin (3,3′,4′,7-tetrahydroxyflavone) is a flavonoid present in fruits and vegetables [77] that possesses anti-cancer [78], anti-inflammatory [79], and antioxidative [80] actions. Suh et al. [43] showed that fisetin treatment inhibited the growth of PC3Cap cells and induced LC3II autophagic marker expression via inhibition of mTOR1/2 signaling. Klimaszewska-Wisniewska et al. observed that combined treatment of fisetin and paclitaxel induced autophagic cell death in A549 non-small-cell lung cancer cells [81].

Oridonin

Treatment with oridonin, an active diterpenoid compound isolated from Rabdosia rubescens, simultaneously induced apoptosis and autophagy via ROS in HeLa cells [82] and human multiple myeloma RPMI8266 cells [83]. Oridonin induced apoptosis and autophagy in human prostate cancer cells [84]. Treatment with the nitric oxide (NO) scavenger DTT and interruption of ERK and p53 activation by PD98059, pifithrin-α, or ERK siRNA decreased oridonin-induced apoptosis and autophagy. This indicates that NO/ERK/p53 inhibited oridonin-induced apoptosis and autophagy in L929 cells [85].

Piperlonguminine

Piperlonguminine, from the long pepper (Piper longum), possesses anti-tumor activity [86] and suppresses the phosphorylation of AKT/mTOR, thereby upregulating ROS levels in several cancer cells, such as 786-O, PC-3, and MCF-7 cell lines [87]. Piperlongumine-induced autophagy depends on ROS activation [87]. Xiong et al. [88] also reported that piperlonguminine significantly induced apoptotic molecules such as Bax, Bcl-2, and caspase-3, autophagic markers such as Beclin-1 and LC3B, phosphorylation of p38 and JNK, and ROS levels in bone marrow mononuclear cells from patients with myeloid leukemia. Piperlonguminine activated p38 protein kinase via ROS, and SB203580, a p38 inhibitor, inhibited piperlonguminine-mediated autophagy [89].

Honokiol

Honokiol, 2-(4-hydroxy-3-prop-2-enyl-phenyl)-4-prop-2-enyl-phenol), a small molecule polyphenol, induced both autophagy and apoptosis via inhibition of the PI3K/AKT/mTOR pathway in neuroblastoma cells [45]. Lu et al. showed that honokiol treatment of human thyroid cancer cells induced anti-tumorigenic effects in vitro and in vivo. LC3-II activity, a marker of autophagy, was increased by honokiol treatment in concentration- and time-dependent manners in thyroid cancer cells [90].

Others

Quercetin

Quercetin, a dietary antioxidant present in fruits and vegetables, is a chemopreventive compound. Wang et al. [42] reported that quercetin induced the appearance of autophagic vacuoles and formation of acidic vesicular organelles, with conversion of LC3-I to LC3-II via modulation of AKT/mTOR and hypoxia-induced factor 1α signaling in gastric cancer cells.

[6]-Gingerol

Treatment with gingerol, which has anti-cancer effects, blocked autophagic flux, and gingerol combined with TRAIL sensitized cell death by blocking autophagic flux in A549 lung adenocarcinoma cells [91].

Glabridin

Glabridin, an isoflavone, induced autophagy and apoptosis in Huh7 human liver cancer cells via activation of JNK1/2. Autophagy inhibitors, such as wortmannin and BafA1, enhanced glabridin-mediated apoptosis [92].

Conclusions

The induction of autophagy is regarded as a strategy for cancer prevention because of its function as a tumor suppressor. Inhibition of the PI3K/AKT/mTOR signaling pathway, which is dysregulated in human tumors, affects autophagy. As shown in Fig. 2 and Table 1, natural agents regulate various autophagic signals. Therefore, finding natural agents that suppress PI3K/AKT/mTOR signaling or induce autophagy may be a good strategy for cancer chemoprevention.

Table 1 Mechanism of natural agents that induce autophagy and apoptosis in cancer cells
Full size table

Abbreviations

AMPK:

AMP-activated protein kinase

CQ:

chloroquine diphosphate

ER:

endoplasmic reticulum

LC3:

microtubule-associated protein light chain 3

mTOR:

mechanistic target of rapamycin

NSCLC:

non-small-cell lung cancer

PI3K:

class III phosphatidylinositol 3-kinase

ROS:

reactive oxygen species

STIM1:

stromal interaction molecule 1

References

  1. Axe EL, Walker SA, Manifava M, Chandra P, Roderick HL, Habermann A, Griffiths G, Ktistakis NT. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J Cell Biol. 2008;182(4):685–701.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Hamasaki M, Furuta N, Matsuda A, Nezu A, Yamamoto A, Fujita N, Oomori H, Noda T, Haraguchi T, Hiraoka Y, et al. Autophagosomes form at ER-mitochondria contact sites. Nature. 2013;495(7441):389–93.

    Article  CAS  PubMed  Google Scholar 

  3. Chan SN, Tang BL. Location and membrane sources for autophagosome formation—from ER-mitochondria contact sites to Golgi-endosome-derived carriers. Mol Membr Biol. 2013;30(8):394–402.

    Article  CAS  PubMed  Google Scholar 

  4. Kamada Y, Funakoshi T, Shintani T, Nagano K, Ohsumi M, Ohsumi Y. Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J Cell Biol. 2000;150(6):1507–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J, Kundu M, Kim DH. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell. 2009;20(7):1992–2003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402(6762):672–6.

    Article  CAS  PubMed  Google Scholar 

  7. Itakura E, Kishi C, Inoue K, Mizushima N. Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol Cell. 2008;19(12):5360–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Kihara A, Noda T, Ishihara N, Ohsumi Y. Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae. J Cell Biol. 2001;152(3):519–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Sun Q, Fan W, Chen K, Ding X, Chen S, Zhong Q. Identification of Barkor as a mammalian autophagy-specific factor for Beclin 1 and class III phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA. 2008;105(49):19211–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 2009;43:67–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Levine B, Kroemer G. Autophagy in aging, disease and death: the true identity of a cell death impostor. Cell Death Differ. 2009;16(1):1–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Mizushima N, Levine B. Autophagy in mammalian development and differentiation. Nat Cell Biol. 2010;12(9):823–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Shang L, Wang X. AMPK and mTOR coordinate the regulation of Ulk1 and mammalian autophagy initiation. Autophagy. 2011;7(8):924–6.

    Article  PubMed  Google Scholar 

  14. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, Thompson CB. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell. 2005;120(2):237–48.

    Article  CAS  PubMed  Google Scholar 

  15. Galluzzi L, Pietrocola F, Bravo-San Pedro JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J, Gewirtz DA, Karantza V, et al. Autophagy in malignant transformation and cancer progression. EMBO J. 2015;34(7):856–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, Jimenez-Sanchez M, Korolchuk VI, Lichtenberg M, Luo S, et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev. 2010;90(4):1383–435.

    Article  CAS  PubMed  Google Scholar 

  17. Mukubou H, Tsujimura T, Sasaki R, Ku Y. The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation. Int J Oncol. 2010;37(4):821–8.

    CAS  PubMed  Google Scholar 

  18. Perera RM, Stoykova S, Nicolay BN, Ross KN, Fitamant J, Boukhali M, Lengrand J, Deshpande V, Selig MK, Ferrone CR, et al. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Nature. 2015;524(7565):361–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA. 2003;100(25):15077–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Carew JS, Nawrocki ST, Kahue CN, Zhang H, Yang C, Chung L, Houghton JA, Huang P, Giles FJ, Cleveland JL. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood. 2007;110(1):313–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Katayama M, Kawaguchi T, Berger MS, Pieper RO. DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ. 2007;14(3):548–58.

    Article  CAS  PubMed  Google Scholar 

  22. Guo JY, Karsli-Uzunbas G, Mathew R, Aisner SC, Kamphorst JJ, Strohecker AM, Chen G, Price S, Lu W, Teng X, et al. Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev. 2013;27(13):1447–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Pyo JO, Jang MH, Kwon YK, Lee HJ, Jun JI, Woo HN, Cho DH, Choi B, Lee H, Kim JH, et al. Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J Biol Chem. 2005;280(21):20722–9.

    Article  CAS  PubMed  Google Scholar 

  24. Kimmelman AC. The dynamic nature of autophagy in cancer. Genes Dev. 2011;25(19):1999–2010.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Ancrile B, Lim KH, Counter CM. Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev. 2007;21(14):1714–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Wei H, Guan JL. Pro-tumorigenic function of autophagy in mammary oncogenesis. Autophagy. 2012;8(1):129–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Inoue D, Suzuki T, Mitsuishi Y, Miki Y, Suzuki S, Sugawara S, Watanabe M, Sakurada A, Endo C, Uruno A, et al. Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci. 2012;103(4):760–6.

    Article  CAS  PubMed  Google Scholar 

  28. Thompson HG, Harris JW, Wold BJ, Lin F, Brody JP. p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells. Oncogene. 2003;22(15):2322–33.

    Article  CAS  PubMed  Google Scholar 

  29. Duran A, Linares JF, Galvez AS, Wikenheiser K, Flores JM, Diaz-Meco MT, Moscat J. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell. 2008;13(4):343–54.

    Article  CAS  PubMed  Google Scholar 

  30. Sun Q, Fan W, Zhong Q. Regulation of Beclin 1 in autophagy. Autophagy. 2009;5(5):713–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Marquez RT, Xu L. Bcl-2: beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch. Am J Cancer Res. 2012;2(2):214–21.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Maiuri MC, Le Toumelin G, Criollo A, Rain JC, Gautier F, Juin P, Tasdemir E, Pierron G, Troulinaki K, Tavernarakis N, et al. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 2007;26(10):2527–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Feng W, Huang S, Wu H, Zhang M. Molecular basis of Bcl-xL’s target recognition versatility revealed by the structure of Bcl-xL in complex with the BH3 domain of Beclin-1. J Mol Biol. 2007;372(1):223–35.

    Article  CAS  PubMed  Google Scholar 

  34. Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol. 2004;5(11):897–907.

    Article  CAS  PubMed  Google Scholar 

  35. Oral O, Oz-Arslan D, Itah Z, Naghavi A, Deveci R, Karacali S, Gozuacik D. Cleavage of Atg3 protein by caspase-8 regulates autophagy during receptor-activated cell death. Apoptosis. 2012;17(8):810–20.

    Article  CAS  PubMed  Google Scholar 

  36. Zhu Y, Zhao L, Liu L, Gao P, Tian W, Wang X, Jin H, Xu H, Chen Q. Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis. Protein Cell. 2010;1(5):468–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Shim JS, Liu JO. Recent advances in drug repositioning for the discovery of new anticancer drugs. Int J Biol Sci. 2014;10(7):654–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Bernstein WB, Dennis PA. Repositioning HIV protease inhibitors as cancer therapeutics. Curr Opin HIV AIDS. 2008;3(6):666–75.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Dolma S, Selvadurai HJ, Lan X, Lee L, Kushida M, Voisin V, Whetstone H, So M, Aviv T, Park N, et al. Inhibition of dopamine receptor D4 impedes autophagic flux, proliferation, and survival of glioblastoma stem cells. Cancer Cell. 2016;29(6):859–73.

    Article  CAS  PubMed  Google Scholar 

  40. Gao H, Sun W, Zhao W, Hao W, Leung CH, Lu J, Chen X. Total tanshinones-induced apoptosis and autophagy via reactive oxygen species in lung cancer 95D cells. Am J Chin Med. 2015;43(6):1265–79.

    Article  CAS  PubMed  Google Scholar 

  41. Meng Y, Lin ZM, Ge N, Zhang DL, Huang J, Kong F. Ursolic acid induces apoptosis of prostate cancer cells via the PI3K/Akt/mTOR pathway. Am J Chin Med. 2015;43(7):1471–86.

    Article  CAS  PubMed  Google Scholar 

  42. Wang K, Liu R, Li J, Mao J, Lei Y, Wu J, Zeng J, Zhang T, Wu H, Chen L, et al. Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR- and hypoxia-induced factor 1alpha-mediated signaling. Autophagy. 2011;7(9):966–78.

    Article  CAS  PubMed  Google Scholar 

  43. Suh Y, Afaq F, Khan N, Johnson JJ, Khusro FH, Mukhtar H. Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells. Carcinogenesis. 2010;31(8):1424–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Ge J, Liu Y, Li Q, Guo X, Gu L, Ma ZG, Zhu YP. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK. Biomed Environ Sci BES. 2013;26(11):902–11.

    CAS  PubMed  Google Scholar 

  45. Yeh PS, Wang W, Chang YA, Lin CJ, Wang JJ, Chen RM. Honokiol induces autophagy of neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular stress/ERK1/2 signaling pathways and suppressing cell migration. Cancer Lett. 2016;370(1):66–77.

    Article  CAS  PubMed  Google Scholar 

  46. Zheng X, Chen W, Hou H, Li J, Li H, Sun X, Zhao L, Li X. Ginsenoside 20(S)-Rg3 induced autophagy to inhibit migration and invasion of ovarian cancer. Biomed Pharmacother Biomed Pharmacother. 2017;85:620–6.

    Article  CAS  PubMed  Google Scholar 

  47. Xavier CP, Lima CF, Pedro DF, Wilson JM, Kristiansen K, Pereira-Wilson C. Ursolic acid induces cell death and modulates autophagy through JNK pathway in apoptosis-resistant colorectal cancer cells. J Nutr Biochem. 2013;24(4):706–12.

    Article  CAS  PubMed  Google Scholar 

  48. Zheng K, Li Y, Wang S, Wang X, Liao C, Hu X, Fan L, Kang Q, Zeng Y, Wu X, et al. Inhibition of autophagosome-lysosome fusion by ginsenoside Ro via the ESR2-NCF1-ROS pathway sensitizes esophageal cancer cells to 5-fluorouracil-induced cell death via the CHEK1-mediated DNA damage checkpoint. Autophagy. 2016;12(9):1593–613.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Sun W, Wang W, Kim J, Keng P, Yang S, Zhang H, Liu C, Okunieff P, Zhang L. Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment. Adv Exp Med Biol. 2008;614:179–86.

    Article  CAS  PubMed  Google Scholar 

  50. Karimi Dermani F, Saidijam M, Amini R, Mahdavinezhad A, Heydari K, Najafi R. Resveratrol inhibits proliferation, invasion, and epithelial–mesenchymal transition by increasing miR-200c expression in HCT-116 colorectal cancer cells. J Cell Biochem. 2016;118:1547.

    Article  PubMed  Google Scholar 

  51. Kavas GO, Ayral PA, Elhan AH. The effects of resveratrol on oxidant/antioxidant systems and their cofactors in rats. Adv Clin Exp Med. 2013;22(2):151–5.

    PubMed  Google Scholar 

  52. Zhong LX, Zhang Y, Wu ML, Liu YN, Zhang P, Chen XY, Kong QY, Liu J, Li H. Resveratrol and STAT inhibitor enhance autophagy in ovarian cancer cells. Cell Death Discov. 2016;2:15071.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Selvaraj S, Sun Y, Sukumaran P, Singh BB. Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway. Mol Carcinog. 2016;55(5):818–31.

    Article  CAS  PubMed  Google Scholar 

  54. Fu Y, Chang H, Peng X, Bai Q, Yi L, Zhou Y, Zhu J, Mi M. Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/beta-catenin signaling pathway. PLoS ONE. 2014;9(7):e102535.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Patel D, Shukla S, Gupta S. Apigenin and cancer chemoprevention: progress, potential and promise (review). Int J Oncol. 2007;30(1):233–45.

    CAS  PubMed  Google Scholar 

  56. Shukla S, Gupta S. Apigenin: a promising molecule for cancer prevention. Pharm Res. 2010;27(6):962–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Lee Y, Sung B, Kang YJ, Kim DH, Jang JY, Hwang SY, Kim M, Lim HS, Yoon JH, Chung HY, et al. Apigenin-induced apoptosis is enhanced by inhibition of autophagy formation in HCT116 human colon cancer cells. Int J Oncol. 2014;44(5):1599–606.

    Article  CAS  PubMed  Google Scholar 

  58. Cao X, Liu B, Cao W, Zhang W, Zhang F, Zhao H, Meng R, Zhang L, Niu R, Hao X, et al. Autophagy inhibition enhances apigenin-induced apoptosis in human breast cancer cells. Chin J Cancer Res Chung-kuo yen cheng yen chiu. 2013;25(2):212–22.

    PubMed  Google Scholar 

  59. Zhang L, Cheng X, Gao Y, Zheng J, Xu Q, Sun Y, Guan H, Yu H, Sun Z. Apigenin induces autophagic cell death in human papillary thyroid carcinoma BCPAP cells. Food Funct. 2015;6(11):3464–72.

    Article  CAS  PubMed  Google Scholar 

  60. Gai WT, Yu DP, Wang XS, Wang PT. Anti-cancer effect of ursolic acid activates apoptosis through ROCK/PTEN mediated mitochondrial translocation of cofilin-1 in prostate cancer. Oncol Lett. 2016;12(4):2880–5.

    PubMed  PubMed Central  Google Scholar 

  61. Kim SH, Ryu HG, Lee J, Shin J, Harikishore A, Jung HY, Kim YS, Lyu HN, Oh E, Baek NI, et al. Ursolic acid exerts anti-cancer activity by suppressing vaccinia-related kinase 1-mediated damage repair in lung cancer cells. Sci Rep. 2015;5:14570.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Shin SW, Kim SY, Park JW. Autophagy inhibition enhances ursolic acid-induced apoptosis in PC3 cells. Biochem Biophys Acta. 2012;1823(2):451–7.

    Article  CAS  PubMed  Google Scholar 

  63. Zhao C, Yin S, Dong Y, Guo X, Fan L, Ye M, Hu H. Autophagy-dependent EIF2AK3 activation compromises ursolic acid-induced apoptosis through upregulation of MCL1 in MCF-7 human breast cancer cells. Autophagy. 2013;9(2):196–207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Leng S, Hao Y, Du D, Xie S, Hong L, Gu H, Zhu X, Zhang J, Fan D, Kung HF. Ursolic acid promotes cancer cell death by inducing Atg5-dependent autophagy. Int J Cancer. 2013;133(12):2781–90.

    CAS  PubMed  Google Scholar 

  65. Zhou L, Zuo Z, Chow MS. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol. 2005;45(12):1345–59.

    Article  CAS  PubMed  Google Scholar 

  66. Jing X, Xu Y, Cheng W, Guo S, Zou Y, He L. Tanshinone I induces apoptosis and pro-survival autophagy in gastric cancers. Cancer Chemother Pharmacol. 2016;77(6):1171–81.

    Article  CAS  PubMed  Google Scholar 

  67. Li C, Han X, Zhang H, Wu J, Li B. The interplay between autophagy and apoptosis induced by tanshinone IIA in prostate cancer cells. Tumour Biol J Int Soc Oncodev Biol Med. 2016;37(6):7667–74.

    Article  CAS  Google Scholar 

  68. Yun SM, Jung JH, Jeong SJ, Sohn EJ, Kim B, Kim SH. Tanshinone IIA induces autophagic cell death via activation of AMPK and ERK and inhibition of mTOR and p70 S6K in KBM-5 leukemia cells. Phytother Res PTR. 2014;28(3):458–64.

    Article  CAS  PubMed  Google Scholar 

  69. Ding L, Wang S, Qu X, Wang J. Tanshinone IIA sensitizes oral squamous cell carcinoma to radiation due to an enhanced autophagy. Environ Toxicol Pharmacol. 2016;46:264–9.

    Article  CAS  PubMed  Google Scholar 

  70. Zhao Z, Li C, Xi H, Gao Y, Xu D. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway. Mol Med Rep. 2015;12(4):5415–22.

    Article  CAS  PubMed  Google Scholar 

  71. Killian PH, Kronski E, Michalik KM, Barbieri O, Astigiano S, Sommerhoff CP, Pfeffer U, Nerlich AG, Bachmeier BE. Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2. Carcinogenesis. 2012;33(12):2507–19.

    Article  CAS  PubMed  Google Scholar 

  72. Zhang J, Wang J, Xu J, Lu Y, Jiang J, Wang L, Shen HM, Xia D. Curcumin targets the TFEB-lysosome pathway for induction of autophagy. Oncotarget. 2016;7:75659.

    PubMed  PubMed Central  Google Scholar 

  73. Guan F, Ding Y, Zhang Y, Zhou Y, Li M, Wang C. Curcumin suppresses proliferation and migration of MDA-MB-231 breast cancer cells through autophagy-dependent Akt degradation. PLoS ONE. 2016;11(1):e0146553.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Xiao K, Jiang J, Guan C, Dong C, Wang G, Bai L, Sun J, Hu C, Bai C. Curcumin induces autophagy via activating the AMPK signaling pathway in lung adenocarcinoma cells. J Pharmacol Sci. 2013;123(2):102–9.

    Article  CAS  PubMed  Google Scholar 

  75. Zhao G, Han X, Zheng S, Li Z, Sha Y, Ni J, Sun Z, Qiao S, Song Z. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells. Oncol Rep. 2016;35(2):1065–74.

    Article  CAS  PubMed  Google Scholar 

  76. Kim DG, Jung KH, Lee DG, Yoon JH, Choi KS, Kwon SW, Shen HM, Morgan MJ, Hong SS, Kim YS. 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin. Oncotarget. 2014;5(12):4438–51.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004;79(5):727–47.

    CAS  PubMed  Google Scholar 

  78. Youns M, Hegazy WAH. The natural flavonoid fisetin inhibits cellular proliferation of hepatic, colorectal, and pancreatic cancer cells through modulation of multiple signaling pathways. PLoS ONE. 2017;12(1):e0169335.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Jeong HY, Sung GH, Kim JH, Yoon JY, Yang Y, Park JG, Kim SH, Yi YS, Yang WS, Yoon DH, et al. Syk and Src are major pharmacological targets of a Cerbera manghas methanol extract with kaempferol-based anti-inflammatory activity. J Ethnopharmacol. 2014;151(2):960–9.

    Article  CAS  PubMed  Google Scholar 

  80. Khan N, Syed DN, Ahmad N, Mukhtar H. Fisetin: a dietary antioxidant for health promotion. Antioxid Redox Signal. 2013;19(2):151–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Klimaszewska-Wisniewska A, Halas-Wisniewska M, Tadrowski T, Gagat M, Grzanka D, Grzanka A. Paclitaxel and the dietary flavonoid fisetin: a synergistic combination that induces mitotic catastrophe and autophagic cell death in A549 non-small cell lung cancer cells. Cancer Cell Int. 2016;16:10.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Zhang YH, Wu YL, Tashiro S, Onodera S, Ikejima T. Reactive oxygen species contribute to oridonin-induced apoptosis and autophagy in human cervical carcinoma HeLa cells. Acta Pharmacol Sin. 2011;32(10):1266–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Zeng R, Chen Y, Zhao S, Cui GH. Autophagy counteracts apoptosis in human multiple myeloma cells exposed to oridonin in vitro via regulating intracellular ROS and SIRT1. Acta Pharmacol Sin. 2012;33(1):91–100.

    Article  CAS  PubMed  Google Scholar 

  84. Li X, Li X, Wang J, Ye Z, Li JC. Oridonin up-regulates expression of P21 and induces autophagy and apoptosis in human prostate cancer cells. Int J Biol Sci. 2012;8(6):901–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Ye YC, Wang HJ, Xu L, Liu WW, Liu BB, Tashiro S, Onodera S, Ikejima T. Oridonin induces apoptosis and autophagy in murine fibrosarcoma L929 cells partly via NO-ERK-p53 positive-feedback loop signaling pathway. Acta Pharmacol Sin. 2012;33(8):1055–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Bezerra DP, Pessoa C, Moraes MO, Alencar NM, Mesquita RO, Lima MW, Alves AP, Pessoa OD, Chaves JH, Silveira ER, et al. In vivo growth inhibition of sarcoma 180 by piperlonguminine, an alkaloid amide from the Piper species. J Appl Toxicol JAT. 2008;28(5):599–607.

    Article  CAS  PubMed  Google Scholar 

  87. Makhov P, Golovine K, Teper E, Kutikov A, Mehrazin R, Corcoran A, Tulin A, Uzzo RG, Kolenko VM. Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death. Br J Cancer. 2014;110(4):899–907.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Xiong XX, Liu JM, Qiu XY, Pan F, Yu SB, Chen XQ. Piperlongumine induces apoptotic and autophagic death of the primary myeloid leukemia cells from patients via activation of ROS-p38/JNK pathways. Acta Pharmacol Sin. 2015;36(3):362–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Wang Y, Wang JW, Xiao X, Shan Y, Xue B, Jiang G, He Q, Chen J, Xu HG, Zhao RX, et al. Piperlongumine induces autophagy by targeting p38 signaling. Cell Death Dis. 2013;4:e824.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Lu CH, Chen SH, Chang YS, Liu YW, Wu JY, Lim YP, Yu HI, Lee YR. Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells. Pharmacol Res. 2017;115:288–98.

    Article  CAS  PubMed  Google Scholar 

  91. Nazim UM, Jeong JK, Seol JW, Hur J, Eo SK, Lee JH, Park SY. Inhibition of the autophagy flux by gingerol enhances TRAIL-induced tumor cell death. Oncol Rep. 2015;33(5):2331–6.

    Article  CAS  PubMed  Google Scholar 

  92. Hsieh MJ, Chen MK, Chen CJ, Hsieh MC, Lo YS, Chuang YC, Chiou HL, Yang SF. Glabridin induces apoptosis and autophagy through JNK1/2 pathway in human hepatoma cells. Phytomed Int J Phytother Phytopharmacol. 2016;23(4):359–66.

    CAS  Google Scholar 

Download references

Authors’ contributions

Conception and design, contribution of reagents, wrote the paper: EJS. HTP designed and prepared the manuscript. Both authors read and approved the final manuscript.

Acknowledgements

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

All data is included in the manuscript.

Consent for publication

The authors consent for publication.

Ethical approval and consent to participate

This article does not contain any studies with human participants and animals performed by any of the authors.

Funding

This was supported by the National Research Foundation of Korea (NRF) Grant funded by Basic Research Program (2015R1C1A1A02036842 and 2016R1A5A2007009).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Author information

Authors and Affiliations

  1. College of Korean Medicine, Kyung Hee University, 1 Hoegi-dong, Dongdaemun-gu, Seoul, 130-701, Republic of Korea

    Eun Jung Sohn

  2. Peripheral Neuropathy Research Center, Department of Physiology, College of Medicine, Dong-A University, Dongdaesin-Dong, Seo-Gu, Busan, 602-714, Republic of Korea

    Eun Jung Sohn & Hwan Tae Park

Authors
  1. Eun Jung Sohn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hwan Tae Park
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eun Jung Sohn.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sohn, E.J., Park, H.T. Natural agents mediated autophagic signal networks in cancer. Cancer Cell Int 17, 110 (2017). https://doi.org/10.1186/s12935-017-0486-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12935-017-0486-7

Keywords

Cancer Cell International

ISSN: 1475-2867

Contact us